Alexion Pharmaceuticals, Inc.
Methods of treating age-related macular degeneration in a patient comprising administering an anti-C5a antibody

Abstract:

The present disclosure relates to, inter alia, a method of treating age-related macular degeneration (AMD) in a patient, comprising administering an effective amount of a C5 inhibitor or a C5a inhibitor.